Published in Clin Exp Allergy on January 01, 2004
Vaccination with genetically engineered allergens prevents progression of allergic disease. Proc Natl Acad Sci U S A (2004) 1.53
Mechanisms underlying allergy vaccination with recombinant hypoallergenic allergen derivatives. Vaccine (2011) 1.01
Genetic engineering of trimers of hypoallergenic fragments of the major birch pollen allergen, Bet v 1, for allergy vaccination. Vaccine (2011) 0.87
Reduction in allergen-specific IgE binding as measured by microarray: A possible surrogate marker for effects of specific immunotherapy. J Allergy Clin Immunol (2015) 0.83
Blocking antibodies in allergen immunotherapy: the Yin and Yang. Clin Exp Allergy (2004) 0.75
Folded or Not? Tracking Bet v 1 Conformation in Recombinant Allergen Preparations. PLoS One (2015) 0.75
Conjugation of wildtype and hypoallergenic mugwort allergen Art v 1 to flagellin induces IL-10-DC and suppresses allergen-specific TH2-responses in vivo. Sci Rep (2017) 0.75
Initial sequencing and analysis of the human genome. Nature (2001) 212.86
The transcriptional program in the response of human fibroblasts to serum. Science (1999) 19.19
An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods (1999) 17.06
A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med (2002) 12.84
A physical map of the human genome. Nature (2001) 12.39
Towards quality management of medical information on the internet: evaluation, labelling, and filtering of information. BMJ (1998) 11.28
Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro. J Exp Med (1985) 11.14
Integration of cytogenetic landmarks into the draft sequence of the human genome. Nature (2001) 10.96
Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood. J Exp Med (2001) 7.86
Proliferating dendritic cell progenitors in human blood. J Exp Med (1994) 7.67
Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J Exp Med (2000) 6.45
Granulocyte/macrophage colony-stimulating factor is essential for the viability and function of cultured murine epidermal Langerhans cells. J Exp Med (1987) 5.64
Responses to unsolicited patient e-mail requests for medical advice on the World Wide Web. JAMA (1998) 5.50
High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10. J Exp Med (1996) 5.29
Identification of proliferating dendritic cell precursors in mouse blood. J Exp Med (1992) 5.03
Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability. J Immunol Methods (1996) 4.87
Granulocyte/macrophage colony-stimulating factor and interleukin 1 mediate the maturation of murine epidermal Langerhans cells into potent immunostimulatory dendritic cells. J Exp Med (1988) 4.79
A systematic, high-resolution linkage of the cytogenetic and physical maps of the human genome. Nat Genet (2000) 4.78
Effect of exercise on coronary endothelial function in patients with coronary artery disease. N Engl J Med (2000) 4.43
Patients looking for information on the Internet and seeking teleadvice: motivation, expectations, and misconceptions as expressed in e-mails sent to physicians. Arch Dermatol (1999) 4.40
Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma. J Exp Med (1999) 4.20
Conjugates of dendritic cells and memory T lymphocytes from skin facilitate productive infection with HIV-1. Cell (1994) 4.04
Regular physical activity improves endothelial function in patients with coronary artery disease by increasing phosphorylation of endothelial nitric oxide synthase. Circulation (2003) 3.86
Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood. J Immunol Methods (1996) 3.80
Immunologic properties of purified epidermal Langerhans cells. Distinct requirements for stimulation of unprimed and sensitized T lymphocytes. J Exp Med (1986) 3.74
Interleukin-12 is produced by dendritic cells and mediates T helper 1 development as well as interferon-gamma production by T helper 1 cells. Eur J Immunol (1996) 3.24
Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical application. J Immunol Methods (1999) 3.09
Regular physical exercise corrects endothelial dysfunction and improves exercise capacity in patients with chronic heart failure. Circulation (1998) 2.90
Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils. J Clin Invest (1986) 2.90
Labeling and filtering of medical information on the Internet. Methods Inf Med (1999) 2.88
The Fc receptor for IgG on human natural killer cells: phenotypic, functional, and comparative studies with monoclonal antibodies. J Immunol (1984) 2.70
Cultured human Langerhans cells resemble lymphoid dendritic cells in phenotype and function. J Invest Dermatol (1989) 2.63
Evaluation of cyberdocs. Lancet (1998) 2.58
Cybermedicine. Interview by Clare Thompson. BMJ (1999) 2.52
Practical guide to skin prick tests in allergy to aeroallergens. Allergy (2011) 2.51
Interleukin-10-treated human dendritic cells induce a melanoma-antigen-specific anergy in CD8(+) T cells resulting in a failure to lyse tumor cells. Blood (1999) 2.47
Effects of exercise training on left ventricular function and peripheral resistance in patients with chronic heart failure: A randomized trial. JAMA (2000) 2.29
Clinical and economic impact of diabetes mellitus on percutaneous and surgical treatment of multivessel coronary disease patients: insights from the Arterial Revascularization Therapy Study (ARTS) trial. Circulation (2001) 2.28
Ultraviolet light depletes surface markers of Langerhans cells. J Invest Dermatol (1981) 2.28
Immature dendritic cells generated with low doses of GM-CSF in the absence of IL-4 are maturation resistant and prolong allograft survival in vivo. Eur J Immunol (2000) 2.24
Mature dendritic cells infected with herpes simplex virus type 1 exhibit inhibited T-cell stimulatory capacity. J Virol (2000) 2.24
A shared antigenic determinant between natural killer cells and nervous tissue. Nature (1984) 2.24
Disappearance of certain acidic organelles (endosomes and Langerhans cell granules) accompanies loss of antigen processing capacity upon culture of epidermal Langerhans cells. J Exp Med (1990) 2.21
Expression of Thy-1 antigen by murine epidermal cells. J Invest Dermatol (1983) 2.20
Antibodies induced with recombinant VP1 from human rhinovirus exhibit cross-neutralisation. Eur Respir J (2010) 2.19
Dendritic cells as vectors for therapy. Cell (2001) 2.18
Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs. J Allergy Clin Immunol (2012) 2.17
Human and murine dermis contain dendritic cells. Isolation by means of a novel method and phenotypical and functional characterization. J Clin Invest (1993) 2.16
Identification of macrophages and dendritic cells in the osteopetrotic (op/op) mouse. J Cell Sci (1993) 2.15
Physical training in patients with stable chronic heart failure: effects on cardiorespiratory fitness and ultrastructural abnormalities of leg muscles. J Am Coll Cardiol (1995) 2.11
Various intensities of leisure time physical activity in patients with coronary artery disease: effects on cardiorespiratory fitness and progression of coronary atherosclerotic lesions. J Am Coll Cardiol (1993) 2.10
Allergen-specific immunotherapy with a monophosphoryl lipid A-adjuvanted vaccine: reduced seasonally boosted immunoglobulin E production and inhibition of basophil histamine release by therapy-induced blocking antibodies. Clin Exp Allergy (2003) 2.08
HIV-1-induced thymocyte depletion is associated with indirect cytopathogenicity and infection of progenitor cells in vivo. Immunity (1995) 2.07
Class II major histocompatibility complex molecules of murine dendritic cells: synthesis, sialylation of invariant chain, and antigen processing capacity are down-regulated upon culture. Proc Natl Acad Sci U S A (1991) 2.06
A radiation hybrid map of mouse genes. Nat Genet (2001) 2.03
The effect of aortic valve replacement on survival. Circulation (1982) 2.03
The CREATE project: development of certified reference materials for allergenic products and validation of methods for their quantification. Allergy (2008) 1.96
Preventing recurrent depression using cognitive therapy with and without a continuation phase: a randomized clinical trial. Arch Gen Psychiatry (2001) 1.93
The Thy-1-bearing cell of murine epidermis. A distinctive leukocyte perhaps related to natural killer cells. J Exp Med (1985) 1.93
The gene coding for the major birch pollen allergen Betv1, is highly homologous to a pea disease resistance response gene. EMBO J (1989) 1.93
Treatment of atypical depression with cognitive therapy or phenelzine: a double-blind, placebo-controlled trial. Arch Gen Psychiatry (1999) 1.90
Factors responsible for differences between asymptomatic subjects and patients presenting an IgE sensitization to allergens. A GA2LEN project. Allergy (2006) 1.84
Breastfeeding duration is a risk factor for atopic eczema. Clin Exp Allergy (2002) 1.84
Is atopy a protective or a risk factor for cancer? A review of epidemiological studies. Allergy (2005) 1.81
Immunological changes during specific immunotherapy of grass pollen allergy: reduced lymphoproliferative responses to allergen and shift from TH2 to TH1 in T-cell clones specific for Phl p 1, a major grass pollen allergen. Clin Exp Allergy (1997) 1.80
Microinjected profilin affects cytoplasmic streaming in plant cells by rapidly depolymerizing actin microfilaments. Curr Biol (1994) 1.70
Allergen immunotherapy: therapeutic vaccines for allergic diseases. World Health Organization. American academy of Allergy, Asthma and Immunology. Ann Allergy Asthma Immunol (1998) 1.70
The immunologic properties of epidermal Langerhans cells as a part of the dendritic cell system. Springer Semin Immunopathol (1992) 1.68
Leukotrienes, LTC4 and LTB4, in bronchoalveolar lavage in bronchial asthma and other respiratory diseases. J Allergy Clin Immunol (1989) 1.63
Mucosal tolerance as therapy of type I allergy: intranasal application of recombinant Bet v 1, the major birch pollen allergen, leads to the suppression of allergic immune responses and airway inflammation in sensitized mice. Clin Exp Allergy (2002) 1.63
Monitoring levels of preservative sensitivity in Europe. A 10-year overview (1991-2000). Contact Dermatitis (2002) 1.63
Identification of profilin as a novel pollen allergen; IgE autoreactivity in sensitized individuals. Science (1991) 1.62
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
Interleukin-5 selectively enhances the chemotactic response of eosinophils obtained from normal but not eosinophilic subjects. Blood (1992) 1.59
The high affinity IgE receptor (Fc epsilon RI) mediates IgE-dependent allergen presentation. J Immunol (1995) 1.59
Catheter-based percutaneous myocardial laser revascularization in patients with end-stage coronary artery disease. J Am Coll Cardiol (1999) 1.58
Four-year follow-up study in patients with angina pectoris and normal coronary arteriograms ("syndrome X") Circulation (1989) 1.57
A comparison of murine epidermal Langerhans cells with spleen dendritic cells. J Invest Dermatol (1985) 1.57
Basophils are not the key antigen-presenting cells in allergic patients. Allergy (2012) 1.57
The profilin multigene family of maize: differential expression of three isoforms. Plant J (1993) 1.56
Prevention of latex allergy by selection of low-allergen gloves. Clin Exp Allergy (2000) 1.55
Incidence of septic and thromboembolic-related deaths after splenectomy in adults. Br J Surg (1989) 1.55
Specific IgE antibodies to platinum salts in sensitized workers. Clin Allergy (1979) 1.54
Vaccination with genetically engineered allergens prevents progression of allergic disease. Proc Natl Acad Sci U S A (2004) 1.53
A comparison of two types of dendritic cell as adjuvants for the induction of melanoma-specific T-cell responses in humans following intranodal injection. Int J Cancer (2001) 1.52
Dissection of immunoglobulin E and T lymphocyte reactivity of isoforms of the major birch pollen allergen Bet v 1: potential use of hypoallergenic isoforms for immunotherapy. J Exp Med (1996) 1.51
Activated human eosinophils generate SRS-A leukotrienes following IgG-dependent stimulation. Nature (1985) 1.51